KUALA LUMPUR, Feb 21 (Bernama) -- Global medical technology company, Smith+Nephew has launched its comprehensive foot and ankle repair portfolio in Australia and New Zealand (ANZ), featuring proprietary adjustable tensioning technology.
Smith+Nephew senior vice president of Sports Medicine, International Markets, Joaquin Lasso said both Australians and New Zealanders are highly active, with over 75 per cent participating in sports and recreational activities.
“Our portfolio of foot and ankle solutions represents a truly groundbreaking introduction for today’s athletes by offering adjustable tensioning technology after anchor insertion, which is not currently available in the ANZ market,” he said in a statement.
Lasso added that this technology allows for personalised treatment, helping patients return to their active lifestyles faster.
This includes the ULTRABRIDGE Adjustable Achilles Reconstruction and ULTRABRACE Adjustable Ankle Instability Techniques, designed to enhance the precision of repairs by allowing surgeons to refine and optimise suture tension after anchor insertion.
This adjustable tensioning technology enables surgeons to customise the range of motion for each patient based on their activity level, offering the opportunity to optimise the repair before finalising the suture. This process aims to restore normal anatomy and potentially improve patient outcomes.
The new portfolio also introduces Smith+Nephew’s top-tier all-suture anchor, now integrated with needles for open procedures, ensuring consistent deployment and strong fixation.
Each year, approximately 230,000 Australians consult a general practitioner for an ankle sprain or strain, highlighting the demand for advanced treatment options.
-- BERNAMA
No comments:
Post a Comment